Remove tag patient-insights
article thumbnail

Grand Rounds October 13, 2023: Incorporating Social Determinants of Health Into PCORnet (Keith Marsolo, PhD)

Rethinking Clinical Trials

Other data, such as immunizations, social determinants of health (SDOH), patient-generated data, and others, may or may not be in the PCORnet Common Data Model and require additional work for use in research. When we talk about patient-level SDOH measures, the CDM has some general purpose tables that can store that data.

article thumbnail

September 30, 2022: CTTI’s Digital Health Trials Hub Recommendations and Resources to Run Your Digital Health Trial (Marianne Chase, MGH, CTTI Team Lead, Jörg Goldhahn, ETH Zurich, CTTI Team Lead)

Rethinking Clinical Trials

The Clinical Trial Transformation Initiative (CTTI) envisions an evidence generating system with trials that are patient-centered, integrated into health processes, quality, leverage all available data, and improve population health. We need to work together to find ways to evaluate the potential benefits and share lessons learned broadly.

Trials 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The FDA and Aduhelm: WTF?

World of DTC Marketing

SKIMMERS SUMMARY: Jefferies analysts found doctors have shown strong interest in prescribing Aduhelm for about 35% of early-stage Alzheimer’s patients with mild cognitive impairment after surveying 50 U.S. neurologists or psychiatrists currently treating about 12,000 Alzheimer’s patients. Not to mention the $56,000 annual price tag.

Drugs 218
article thumbnail

Grand Rounds February 3, 2023: Pragmatic Trials For Children With Congenital Heart Disease – Insights From The NITRIC Trial (Luregn Schlapbach, PhD, FCICM)

Rethinking Clinical Trials

All patients could receive inhalation NO during/after surgery if considered indicated by the treatment team. 1,371 patients were randomized with 1,364 in the final analysis. The intervention was applied by perfusionists at a steady concentration from the start until the end of bypass. All other surgical staff were blinded.

Trials 130
article thumbnail

Revolutionizing Medicine and Public Health: The Emergence of Big Data in Healthcare

Roots Analysis

Velocity: Big Data needs to be handled promptly as businesses generate data at an unprecedented speed, driven by the growing adoption of Internet of Things (IoT), and technologies, such as RFID tags, sensors, and smart meters are used to deal with the high velocity of data in real-time. It is loosely arranged into categories using meta tags.

article thumbnail

AI-Powered Precision Engagement in Commercial and Medical Functions

Intouch Solutions

Commercial : Improved experience and communication between patients and doctors. It uses customer insights to deliver personalized experiences. In the pharma industry, precision engagement can be used to present patients, healthcare professionals (HCPs), and other stakeholders with relevant information and support at the right time.

article thumbnail

Targeting a human protein may stop Ebola virus in its tracks

The Pharma Data

Unfortunately, in a Phase 3 clinical trial, treatment with remdesivir did not make a difference in mortality for Ebola virus disease patients. ” These insights were made possible thanks to an enzyme, called split-TurboID, which is a biotin ligase engineered by the lab of Stanford University Professor Alice Ting, Ph.D.

Protein 52